Hematological Consequences of Parvovirus B19 Infection
Keywords:
-Abstract
-
Downloads
References
เอกสารอ้างอิง
Mietzsch M, Pénzes JJ, Agbandje-McKenna M. Twenty-Five Years of Structural Parvovitology. Viruses. 2019; 11.
Ozawa K, Ayub J, Kajigaya S, Shimada T, N Young. The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol. 1988; 62:2884
Xu P, Zhou Z, Xiong M, Zou W, Deng X, Ganaie S, et al. Parvovirus B19 NS1 protein induces cell cycle arrest at G2-phase by activating the ATR-CDC25C-CDK1 pathway. PLoS Pathog 2017;13:e1006266.
Moffatt S, Yaegashi N, Tada K, Tanaka N, Sugamura. Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells. J Virol. 1998;72:3018.
Jordan JA, Butchko AR. Apoptotic activity in villous trophoblast cells during B19 infection correlates with clinical outcome:
assessment by the caspase-related M30 Cytodeath antibody. Placenta. 2002;23:547.
Moffatt S, Tanaka N, Tada K, Nose M, Nakamura M, Muraoka O, et al. A cytotoxic nonstructural protein, NS1, of human parvovirus
B19 induces activation of interleukin-6 gene expression. J Virol. 1996; 70:8485.
Fu Y, Ishii KK, Munakata Y, Saitoh T, Kaku M, Sasaki T. Regulation of tumor necrosis factor alpha promoter by human parvovirus B19
NS1 through activation of AP-1 and AP-2. J Virol. 2002;76:5395.
Nakashima A, Morita E, Saito S, Sugamura K. Human Parvovirus B19 nonstructural protein transactivates the p21/WAF1 through
Sp1. Virology. 2004;329:493.
Mortimer PP, Humphries RK, Moore JG, Purell RH, Young NS. A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature. 1983;302:426.
Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science. 1993; 262:114.
Jordan JA, DeLoia JA. Globoside expression within the human placenta. Placenta. 1999;20:103.
Rouger P, Gane P, Salmon C. Tissue distribution of H, Lewis and P antigens as shown by a panel of 18 monoclonal antibodies. Rev Fr Transfus Immunohematol. 1987;30:699.
Naides SJ. Erythema infectiosum (fifth disease) occurrence in Iowa. Am J Public Health. 1988;78:1230.
Serjeant GR, Serjeant BE, Thomas PW, Anderson MJ, Patou G, Pattison JR. Human parvovirus infection in homozygous sickle cell disease. Lancet. 1993;341:1237.
Yamashita K, Matsunaga Y, Taylor-Wiedeman J, Yamazaki S. A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade. Jpn J Med Sci Biol. 1992;45:49.
Suandork P, Poovorapan Y. Parvovirus B19. Chula Med J. 2000;44:819-30
Frickhofen N, Abkowitz JL, Safford M, Berry JM, Antunez-de-Mayolo J, Astrow A, Halperin I, King L, Cohen R. Persistent B19 parvovirus
infection in patient infected with human immunodeficiency virus type 1 (HIV-1). A treatable cause of anemia in AIDs. Ann Intern Med. 1990 Dex 15; 113 : 926-33
Koch WC, Massey G, Russell CE, Adler SP. Manifestation and treatment of human parvovirus B19 infection in immunocompromised
patients. J Pediatr. 1990;116:355-9
Yoto Y, Kudoh T, Suzuki N, Matsunaga Y, Chiba Y. Retrospective study on the influence of human parvovirus B19 infection among children with malignant diseases. Acta Haematol. 1993;90:8-12
Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, et al. Experimental parvoviral infection in humans. J Infect Dis. 1985;152:257.
Anderson Lj. Role of parvovirus B19 in human disease. Pediatr Infect Dis J. 1987;6:711.
Lindblom A, Isa A, Norbeck O, Wolf S, Johansson B, Broliden K, et al. Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis. 2005;41:1201.
Lowry SM, Brent LH, Menaldino S, Kerr JR. A case of persistent parvovirus B19 infection with bilateral cartilaginous and ligamentous damage to the wrists. Clin Infect Dis. 2005;41:e42.
Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev. 2002;15:485.
Nguyen QT, Wong S, Heegaard ED, Brown KE. Identification and characterization of a second novel human erythrovirus variant, A6. Virology. 2002;301:374.
Shimamura A, Guinan G. Acquired aplastic anemia. In: Nathan and Oski’s hematology of infancy and childhood, 6th ed, Nathan DG, Orkin SH, Ginsberg D, Lool at. editors, WB Suanders, Philadelphia, 2003. p. 256.
Saarinen UM, Chorba TL, Tattersall P, Young NS, Anderson LJ, Palmer E, et al. Human parvovirus B19-induced epidemic acute
red red cell aplasia in patients with hereditary hemolytic anemia. Blood. 1986;67:1411.
Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004;350:586.
Lauharurayotin S, Sosothikul D. Single Cytopenia. In: Pediatric Hematology, Sosothikul D, editor. Beyond Enterprises LLC, Nonthaburi. 2019:152-64.
Kurtzman G, Frickhofen N, Kimball J, Jenkins DW, Nienhuis AW, Young NS. Pure red-cell aplasia of 10 years’ duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N Engl J Med. 1989;321:519.
Vales-Albertos LJ, García-Cárdenas M, Chávez-Becerra S, Gomez-Navarro B, Monteon-Ramos F, Cueto-Manzano AM. Pure red cell aplasia associated with parvovirus B19 infection in renal transplantation: the first case report in Mexico. Transplantation 2005;79:739.
Plentz A, Hahn J, Holler E, Jilg W, Modrow S. Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation. J Clin Virol. 2004;26:497.
Fattet S, Cassinotti P, Popovic MB. Persistent human parvovirus B19 infection in children under maintenance chemotherapy for acute lymphocytic leukemia. J Pediatr Hematol Oncol. 2004;26:497.
Koduri PR. Parvovirus B19-related anemia in HIV-infected patients, AIDS Patient Care STDS. 2000;14:7.
Chen MY, Hung CC, Fang CT, Hsieh SM. Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapy. Clin Infect Dis. 2001;32:1361.
Razonable RR. Not the Usual Viral Suspects: Parvovirus B19, West Nile Virus, and Human T-Cell Lymphotrophic Virus Infections after Kidney Transplantation. Semin Nephrol. 2016;36:428.
Ahmed W, Dogar RUH, Acharya S. Parvovirus B19: A rare Cause of Post-renal Transplant Anemia. J Coll Physicians Surg Pak. 2017; 27:785.
Pakkyara A, Jha A, Al Salmi I, Siddiqi WA, Al Rahbi N, Kurkulasurya AP, et al. Persistent anemia in a kidney transplant recipient with
parvovirus B19 infection. Saudi J Kidney Dis Tranpl. 2017;28:1447.
Aguiar FS, Lopes DP, Bazin AR, Setubal S, Cohen BJ, Nascimento JP. Human parvovirus B19 infection in HIV-positive patients. Rev Soc Bras med Trop. 2001;34:239.
Broliden K, Tolfvenstam T, Ohlsson S, Henter JI. Persistent B19 parvovirus infection in pediatric malignancies. Med Pediatr
Oncol. 1998;31:66.
Heegaard ED, Schmiegelow K. Serologic study on parvovirus B19 infection in childhood acute lymphoblastic leukemia during
chemotherapy: clinical and hematologic implications. J Pediatr Hematol Oncol. 2002; 24:368.
Moreux N, Ranchin B, Calvet A, Gabriel B, Helene LA. Chronic parvovirus B19 infection a pediatric lung transplanted patient.
Transplantation. 2002;73:565.
Kurtzman GJ, Cohen B, Meyers P Amunullah A, Young NS. Persistent B19 parvovirus infection as a cause of severe chronic
anaemia in children with acute lymphocytic leukaemia. Lancet 1988;2:1159.
Cassinotti P, Burtonboy G, Fopp M, Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol. 1997; 53:229.
Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006;43:40.
Barah F, Whiteside S, Batista S, Morris J. Neurological aspects of human parvovirus B19 infection: a systemic review. Rev Med Virol. 2014;24:154.
Finkel TH, TÖrÖk TJ, Ferguson PJ, Durigon EL, Zaki SR, Leung DY, et al. Chronic parvovirus B19 infection and systemic necrotizing
vasculitis: opportunistic infection or aetiological agent. Lancet. 1994;343:1255.
Heegaard ED, Eiskjaer H, Baansrup U, Hornsleth A. Parvovirus B19 infection associated with myocarditis following adult cardiac
transplantation. Scand J Infect Dis. 1998;30:607.
Torok TJ. Unusual clinical manifestations reported in patients with parvovirus B19 infection. In: Monographs in Virology: Human Parvovirus B19. Anderson LJ, Young ND (Eds). Karger, New York. 1997. p. 61.
KnÖsel T, Meisel H, Borgmann A, Riebel T, Krenn V, Schewe C, et al. Parvovirus B19 infection associated with unilateral cervical
lymphadenopathy, apoptotic sinus histiocytosis, and prolonged fatigue. J Clin Pathol. 2005;58:872.
Alvarez-Lafuente R, Fernández-Gutiérrez B, Jover JA, Judez E, Loza E, Clemente D, et al. Human parvovirus B19, varicella zoster virus,
and human herpes virus 6 in temporal artery biopsy specimens of patient with giant cell arteritis: analysis with quantitative real time polymerase chain reaction. Ann Rheum Dis. 2005;64:780.
Aktepe OC, Yetgin S, Olcay L, Ozbek N. Human parvovirus B19 associated with idiopathic thrombocytopenia purpura. Pediatr
Hematol Ocol. 2004;21:421.
Shitono K, Tsuda H. Parvovirus B19-associated haemophagocytic syndromw in healthy adults. Br J Haematol. 1995;89:923.
Wiggli B, Imhof E, Meier CA, Laifer G. Water, water, everywhere. Acute parvovirus B19 infection. Lancet. 2013;381:776.
Jordan JA. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Eschericia coli-based VP1 EIA for detection
of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women. J Clin Microbiol. 2000;38:1472
Butchko AR, Jordan JA. Comparison of three commercially available serologic assays used to detect human parvovirus B19-specific
immunoglobulin M (IgM) and IgG antibodies in sera of pregnant women. J Clin Microbiol. 2004;42:3191.
Schwarz TF, Jáger G, Gilch S. Comparison of seven commercial tests for the detection of parvovirus B19-specific IgM. Zantralbl
Bakteriol. 1997;285:525.
Erdman DD, Usher Mj, Tsou C, Caul EO, Gary GW, Kajigaya S, et al. Human parvovirus B19 specific IgG, IgA and IgM antibodies
and DNA in serum specimens from persons with erythema infectiosum. J Med Virol. 1991;35:110.
Beersma MF, Claas EC, Sopaheluakan T, Kroes AC. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples. J Clin Virol. 2005;34:71.
Kleinman SH, Glynn SA, Lee TH, Tobler L, Montalvo L, Todd D, et al. Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion. 2007;47:1756.
Musiani M, Zerbini M, Gentilomi G, Plazzi M, Gallinella G, Venturoli S. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis. 1995;172:1360.
Chen MY, Hung CC, Fang CT, Hsieh SM. Reconstituted immunity against persistent parvovirus B19 infection in a patient
with acquired immunodeficiency syndrome after highly active antiretroviral therapy. Cli Infect Dis. 2001;32:1361.
Broliden K. Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation. Pediatr Transplant. 2001;5:320-30.
Bonvicini F, Mirasoli M, Gallinella G, Zerbini M, Musiani M, Roda A. PNA-bases probe for quantitative chemilumninescent
in situ hybridization imaging of cellular parvovirus B19 replication kinetics. Analyst. 2007,132:519-23.
Goldstein AR, Anderson MJ, Serjeant GR. Parvovirus associated aplastic crisis in homozygous sickle cell disease. Arch Dis Child.
;62:585.
Kumar J, Shaver MJ, Abul-Ezz S. Long-term remission of recurrent parvovirus-B associated anemia in a renal transplant recipient
induced by treatment with immunoglobulin and positive seroconversion. Transpl Infect Dis. 2005;7:30-3.
Albert J Eid, Monica I Ardura. The AST Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ
transplantation: Guidelines from the American society of transplantation infectious diseases community of practice. Clinical
Transplantation. 2019;33:e13535.
Crabol Y, Terrier B, Rozenberg F, Pestre V, Legendre C, Hermine O, et al. Intravenous immunoglobulin therapy for pure red cell
aplasia related to human parvovirus B19 infection: a retrospective study of 10 patient and review of the literature. Clin Infect Dis.
;56:968.
Bonvicini F, Bua G, Manaresi E, Gallinella G. Antiviral effect of cidofovir on parvovirus B19 replication. Antiviral Res. 2015;113:11-8.
Bonvincini F, Bua G, Manaresi E, Gallinella G. Enhanced inhibition of parvovirus B19 replication by cidofovir in extendedly exposed erythroid progenitor cells. Virus Res. 2016;220:47-51.
Bonvincini F, Bua G, Conti I, Manaresi E, Gallinella G. Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells. Biochem Pharmacol. 2017;136:32-9.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Journal of Hematology and Transfusion Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
